1. Show article details.

    ZELTIQ Announces Save the Date for 2015 Investor Day

    Market Wire – 5:17 PM ET 08/17/2015

    08/17/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that it will host an investor and analyst day in New York, NY on November 17th 2015 from 9:30 a.m. ET to 12:00 p.m. ET. The event will focus on the Company's growth initiatives, R&D pipeline and financial outlook.

  2. Show article details.

    ZELTIQ to Present at the Canaccord Genuity 35th Annual Growth Conference

    Market Wire – 7:50 PM ET 08/11/2015

    08/11/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference in Boston, MA. Event: Canaccord Genuity 35th Annual Growth Conference Date: Wed...

  3. Show article details.

    ZELTIQ Announces Second Quarter 2015 Financial Results

    Market Wire – 4:05 PM ET 07/30/2015

    07/30/15 -- ZELTIQ® ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for the second quarter 2015. Mark Foley, President and Chief Executive Officer, said, "The second quarter of 2015 was an exceptionally strong quarter across all areas of our business.

  4. Show article details.

    ZELTIQ Announces Conference Call and Webcast of Second Quarter 2015 Financial Results to Be Held on July 30, 2015

    Market Wire – 4:05 PM ET 07/16/2015

    07/16/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its second quarter 2015 financial results on Thursday, July 30, 2015 after the market close.

  5. Show article details.

    ZELTIQ to Participate at Investor Conferences in June 2015

    Market Wire – 9:00 AM ET 05/20/2015

    05/20/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in three investor conferences in June 2015.

  6. Show article details.

    ZELTIQ(R) Aesthetics Reaches 2,000,000th CoolSculpting(R) Treatment Cycle Milestone

    Market Wire – 5:02 PM ET 05/14/2015

    05/14/15 -- ZELTIQ® Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it recently shipped its 2,000,000th CoolSculpting treatment cycle.

  7. Show article details.

    ZELTIQ Announces First Quarter 2015 Financial Results

    Market Wire – 4:05 PM ET 05/05/2015

    05/05/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for the first quarter 2015.

  8. Show article details.

    ZELTIQ Announces Conference Call and Webcast of First Quarter 2015 Financial Results to Be Held on May 5, 2015

    Market Wire – 4:05 PM ET 04/21/2015

    04/21/15 -- ZELTIQ®, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its first quarter 2015 financial results on Tuesday, May 5, 2015 after the market close.

  9. Show article details.

    CoolSculpting(R) Procedure Named "Best Non-Surgical Procedure" by JEZEBEL Magazine

    Market Wire – 4:30 PM ET 04/08/2015

    04/08/15 -- ZELTIQ® Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that its CoolSculpting procedure has been awarded the 2015 "Best Non-Surgical Procedure" in Atlanta by JEZEBEL magazine.

  10. Show article details.

    ZELTIQ(R) Aesthetics Showcasing New CoolSmooth PRO(TM) Applicator at American Academy of Dermatology Annual Meeting

    Market Wire – 5:00 PM ET 03/19/2015

    03/19/15 -- ZELTIQ® Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is showcasing its CoolSmooth PRO™ applicator, a second generation surface applicator featuring non-vacuum based cooling to treat non-pinchable fat bulges such as the outer thigh area, at the...

Page:

Today's and Upcoming Events

  • Oct
    27

    ZLTQ to announce Q3 earnings After Market (Unconfirmed)

  • Nov
    17

    ZELTIQ Analyst Day
    11/17/2015 to 11/17/2015 9:00 AM EST , New York City, NY Listen

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.